Edition:
India

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

6,408.00GBp
22 Mar 2019
Change (% chg)

-130.00 (-1.99%)
Prev Close
6,538.00
Open
6,505.00
Day's High
6,518.00
Day's Low
6,400.00
Volume
973,359
Avg. Vol
1,307,818
52-wk High
7,174.00
52-wk Low
5,255.00

Latest Key Developments (Source: Significant Developments)

Reckitt Benckiser Reports FY Adjusted Diluted EPS Of 339.9 Pence
Monday, 18 Feb 2019 

Feb 18 (Reuters) - Reckitt Benckiser Group PLC ::FY REVENUE ROSE 3 PERCENT TO 12.6 BILLION STG.FY ADJUSTED DILUTED EPS 339.9 PENCE.REMAIN ON TRACK TO ACHIEVE OUR INCREASED SYNERGY TARGET OF $300M..2019 LFL NET REVENUE GROWTH TARGETED AT +3-4%.QTRLY NET REVENUE FROM CONTINUING OPERATIONS 3,339 MILLION STG VERSUS 3,289 MILLION STG REPORTED LAST YEAR.ADJUSTED OPERATING MARGIN EXPECTED TO BE MAINTAINED IN 2019.FY NET REVENUE FROM CONTINUING OPERATIONS 12,597 MILLION STG VERSUS 11,512 MILLION STG REPORTED LAST YEAR.FY EARNINGS PER SHARE FROM CONTINUING OPERATIONS 305.5 PENCE.FY LIKE-FOR-LIKE NET REVENUE GROWTH FROM CONTINUING OPERATIONS OF +4% AT CONSTANT EXCHANGE.RECOMMENDS A FINAL DIVIDEND OF 100.2P PER SHARE (2017: 97.7P), AN INCREASE OF +3%..RECKITT BENCKISER GROUP - ALSO UNDER WAY IN THE SEARCH FOR A SUCCESSOR TO RAKESH KAPOOR, WHETHER INTERNAL OR EXTERNAL.MJN COST SYNERGIES IN 2018 WERE £158M ($211M) AND A CUMULATIVE TOTAL OF £178M ($236M) TO END OF 2018.RECKITT BENCKISER-IN 2019 EXPECT REMAINING SYNERGIES FROM MJN DEAL TO BE BROADLY OFFSET BY SMALL INCREASE IN OPERATING COSTS RELATED TO RB2.0 INFRASTRUCTURE.WILL TAKE UNTIL MID-2020 TO COMPLETE "INFRASTRUCTURE" CHANGES UNDER RB2.0.  Full Article

Reckitt Benckiser Says Rakesh Kapoor To Retire As CEO
Wednesday, 16 Jan 2019 

Jan 16 (Reuters) - Reckitt Benckiser Group PLC ::RAKESH KAPOOR TO RETIRE AS CEO BY END OF 2019.BOARD HAS INITIATED A SEARCH FOR NEW CEO AND IS CONSIDERING INTERNAL AND EXTERNAL CANDIDATES.  Full Article

Reckitt Benckiser sees no change to med-term profit guidance
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CEO SAYS WITHOUT MANUFACTURING DISRUPTION, INFANT NUTRITION WOULD HAVE BEEN UP 3 PERCENT YTD.RECKITT BENCKISER CEO SAYS AFFECTED FACILITY WAS IN THE NETHERLANDS, AND SUFFERED A TECHNICAL ENGINEERING ISSUE.RECKITT BENCKISER CFO SAYS NO CHANGE TO MEDIUM TERM MARGIN GUIDANCE.RECKITT BENCKISER CFO SAYS DOES NOT EXPECT ANY SUBSTANTIAL IMPACT ON BUSINESS FROM BREXIT.  Full Article

Glaxo Seeks Bids Mid-September For $4 Bln India Sale- Bloomberg
Tuesday, 21 Aug 2018 

Aug 21 (Reuters) - :GLAXO SEEKS BIDS MID-SEPTEMBER FOR $4 BILLION INDIA SALE- BLOOMBERG,CITING SOURCES.GLAXO'S INDIA SALE HAS ATTRACTED INTEREST FROM POTENTIAL BIDDERS INCLUDING NESTLE, PEPSICO AND RECKITT BENCKISER - BLOOMBERG,CITING SOURCES.  Full Article

Reckitt Benckiser Says Have Decided To Recall An Affected Batch Of Durex Extra Lubricated 10Ct Condoms
Tuesday, 7 Aug 2018 

Aug 7 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER (CANADA) INC SAYS HAVE DECIDED TO RECALL AN AFFECTED BATCH OF DUREX REAL FEEL EXTRA LUBRICATED 10CT CONDOMS.  Full Article

Reckitt Benckiser Appoints Mehmood Khan To Board
Tuesday, 26 Jun 2018 

June 26 (Reuters) - Reckitt Benckiser Group Plc ::APPOINTMENT OF MEHMOOD KHAN TO BOARD, WITH EFFECT FROM JULY 1 ST 2018 .KHAN WILL ALSO JOIN RB'S CORPORATE RESPONSIBILITY, SUSTAINABILITY, ETHICS AND COMPLIANCE COMMITTEE.  Full Article

Aspen's Infant Formula Unit Is Said To Draw Reckitt, Perrigo - Bloomberg
Wednesday, 16 May 2018 

May 16 (Reuters) - :ASPEN'S INFANT FORMULA UNIT IS SAID TO DRAW RECKITT, PERRIGO - BLOOMBERG, CITING SOURCES.FRENCH DAIRY GROUP LACTALIS AND AUSTRALIA'S INOVA PHARMACEUTICALS ARE ALSO WEIGHING OFFERS FOR A STAKE IN ASPEN'S INFANT FORMULA UNIT - BLOOMBERG.  Full Article

JAB Holdings BV Cuts Stake In Reckitt Benckiser To 3.68 Pct - Filing
Wednesday, 9 May 2018 

May 9 (Reuters) - Filing::JAB HOLDINGS BV CUTS STAKE IN RECKITT BENCKISER TO 3.68 PERCENT FROM 4.87 PERCENT EARLIER - FILING.  Full Article

Reckitt Benckiser Q1 Revenue Up 23 Pct at 3.11 Bln Stg
Friday, 20 Apr 2018 

April 20 (Reuters) - Reckitt Benckiser Group PLC ::Q1 REVENUE OF 3,111 MILLION STG.Q1 REVENUE GROWTH OF +23% ON A REPORTED BASIS.Q1 TOTAL LIKE-FOR-LIKE SALES +2 PERCENT.ON TRACK FOR FULL YEAR NET REVENUE TARGET OF +13-14% (TOTAL CONSTANT), IMPLYING +2%-3% LFL.Q1 HEALTH LIKE-FOR-LIKE SALES +1% PERCENT.Q1 DVM LIKE-FOR-LIKE SALES OF +4% PERCENT.MEAD JOHNSON NUTRITION PERFORMANCE CONTINUES TO PROGRESS WELL WITH PROFORMA GROWTH +6% FOR Q1.Q1 TOTAL NORTH AMERICA LIKE-FOR-LIKE SALES OF +6%."SOLID START OVERALL IN Q1, OPERATING UNDER OUR NEW ORGANISATIONAL STRUCTURE".Q1 EUROPE/ ANZ LIKE-FOR-LIKE SALES OF -1% .RECKITT BENCKISER GROUP PLC - "RB 2.0 IS EMBEDDING WELL" AND EXPECT TO SEE BENEFITS CONTINUE TO MATERIALISE".SAW CONTINUED CHALLENGING CONDITIONS IN BOTH MIDDLE EAST AND ASEAN MARKETS IN Q1.  Full Article

Reckitt Benckiser Ends Discussions For Parts Of Pfizer's Consumer Health business
Thursday, 22 Mar 2018 

March 21 (Reuters) - Reckitt Benckiser Group Plc ::RECKITT BENCKISER SAYS PULLS OUT OF PFIZER CONSUMER HEALTH AUCTION.CO'S PROPOSAL WAS FOR PART OF THE BUSINESS ONLY.RECKITT BENCKISER - ACQUISITION FOR WHOLE PFIZER CONSUMER HEALTH BUSINESS DID NOT FIT ACQUISITION CRITERIA, ACQUISITION OF PART OF BUSINESS WAS NOT POSSIBLE.  Full Article

UPDATE 1-UK Stocks-Factors to watch on Feb 19

Feb 19 Britain's FTSE 100 index is seen opening 8 points higher at 7,228 on Tuesday, according to financial bookmakers, while FTSE 100 futures were down 0.03 percent ahead of the cash market open.